By 2028, the pharmaceutical CDMO market is projected to grow at a CAGR of 6.74% and reach $309.5 billion. They stand to be the best partners to help the industry adapt to new trends such as small molecule drugs and personalized medicine. The future is promising for CDMOs!
https://www.lannettcdmo.com/
Like
Comment
Share
